W Al Sarakbi

514 total citations
11 papers, 371 citations indexed

About

W Al Sarakbi is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, W Al Sarakbi has authored 11 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in W Al Sarakbi's work include Estrogen and related hormone effects (4 papers), Breast Lesions and Carcinomas (3 papers) and Cancer Risks and Factors (2 papers). W Al Sarakbi is often cited by papers focused on Estrogen and related hormone effects (4 papers), Breast Lesions and Carcinomas (3 papers) and Cancer Risks and Factors (2 papers). W Al Sarakbi collaborates with scholars based in United Kingdom and United States. W Al Sarakbi's co-authors include Kefah Mokbel, M Salhab, Wen G. Jiang, Walid Sasi, R. F. Newbold, Timothy Roberts, Michael Reed, Val Thomas and Umar Wazir and has published in prestigious journals such as Breast Cancer Research and Treatment, BMC Cancer and Journal of Carcinogenesis.

In The Last Decade

W Al Sarakbi

11 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Al Sarakbi United Kingdom 8 128 113 108 106 68 11 371
Hideaki Aoyama Japan 10 74 0.6× 218 1.9× 120 1.1× 61 0.6× 40 0.6× 24 382
Katie A. Ashton Australia 12 224 1.8× 170 1.5× 120 1.1× 107 1.0× 19 0.3× 23 457
Shigeru Tsuyuki Japan 10 79 0.6× 163 1.4× 80 0.7× 32 0.3× 65 1.0× 32 378
Rolf Kaaresen Norway 12 138 1.1× 212 1.9× 165 1.5× 51 0.5× 124 1.8× 23 450
C. Bélichard France 9 78 0.6× 79 0.7× 150 1.4× 38 0.4× 64 0.9× 17 306
Baha Zengel Türkiye 9 111 0.9× 180 1.6× 190 1.8× 100 0.9× 76 1.1× 44 426
King Xin Koh Singapore 7 242 1.9× 100 0.9× 185 1.7× 37 0.3× 90 1.3× 8 440
Panagiota Tsioli Greece 9 126 1.0× 112 1.0× 46 0.4× 101 1.0× 18 0.3× 10 317
Woo Gyeong Kim South Korea 11 68 0.5× 134 1.2× 60 0.6× 61 0.6× 49 0.7× 36 330
Patel Dd India 12 165 1.3× 165 1.5× 107 1.0× 55 0.5× 73 1.1× 28 416

Countries citing papers authored by W Al Sarakbi

Since Specialization
Citations

This map shows the geographic impact of W Al Sarakbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Al Sarakbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Al Sarakbi more than expected).

Fields of papers citing papers by W Al Sarakbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Al Sarakbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Al Sarakbi. The network helps show where W Al Sarakbi may publish in the future.

Co-authorship network of co-authors of W Al Sarakbi

This figure shows the co-authorship network connecting the top 25 collaborators of W Al Sarakbi. A scholar is included among the top collaborators of W Al Sarakbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Al Sarakbi. W Al Sarakbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wazir, Umar, W Al Sarakbi, Wen G. Jiang, & Kefah Mokbel. (2012). Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.. PubMed. 9(6). 383–7. 13 indexed citations
2.
Sarakbi, W Al, Walid Sasi, Wen G. Jiang, et al.. (2009). The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer. 9(1). 290–290. 98 indexed citations
3.
Sarakbi, W Al, et al.. (2007). The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.. PubMed. 26(6C). 4985–90. 49 indexed citations
4.
Sarakbi, W Al, et al.. (2006). Breast papillomas: current management with a focus on a new diagnostic and therapeutic modality. PubMed. 3(1). 1–1. 59 indexed citations
5.
Sarakbi, W Al, et al.. (2006). The mRNA expression of IGF-1 and IGF-1R in human breast cancer: association with clinico-pathological parameters.. Journal of Carcinogenesis. 5(1). 16–16. 5 indexed citations
6.
Salhab, M, Michael Reed, W Al Sarakbi, Wen G. Jiang, & Kefah Mokbel. (2006). The role of aromatase and 17-β-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Breast Cancer Research and Treatment. 99(2). 155–162. 32 indexed citations
7.
Sarakbi, W Al, M Salhab, & Kefah Mokbel. (2006). Dairy products and breast cancer risk: a review of the literature.. PubMed. 50(6). 244–9. 10 indexed citations
8.
Sarakbi, W Al, et al.. (2006). The role of steroid sulfatase (STS) and organic anion transporter polypeptide B(OATP B) mRNA expression in predicting the clinical outcome in human breast cancer. European Journal of Cancer Supplements. 4(2). 141–141. 1 indexed citations
9.
Salhab, M, W Al Sarakbi, & Kefah Mokbel. (2005). Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. PubMed. 2(1). 26–26. 71 indexed citations
10.
Sarakbi, W Al, et al.. (2005). SYK expression in human breast cancer.. Journal of Carcinogenesis. 4(1). 7–7. 7 indexed citations
11.
Sarakbi, W Al, M Salhab, Val Thomas, & Kefah Mokbel. (2005). Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer?. PubMed. 2(1). 15–15. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026